These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14575146)

  • 1. Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus.
    Li H; Ding J; Chen YH
    Immunobiology; 2003; 207(5):305-13. PubMed ID: 14575146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A candidate vaccine against influenza virus intensively improved the immunogenicity of a neutralizing epitope.
    Lu Y; Ding J; Liu W; Chen YH
    Int Arch Allergy Immunol; 2002 Mar; 127(3):245-50. PubMed ID: 11979050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
    Kitikoon P; Strait EL; Thacker EL
    Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A.
    Zhong Y; Cai J; Zhang C; Xing X; Qin E; He J; Mao P; Cheng J; Liu K; Xu D; Song H
    Virol J; 2011 Dec; 8():542. PubMed ID: 22171803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.
    Chen S; Zheng D; Li C; Zhang W; Xu W; Liu X; Fang F; Chen Z
    Biomed Res Int; 2015; 2015():901817. PubMed ID: 25767809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies.
    Honda T; Gomi S; Yamane D; Yasui F; Yamamoto T; Munakata T; Itoh Y; Ogasawara K; Sanada T; Yamaji K; Yasutomi Y; Tsukiyama-Kohara K; Kohara M
    mSphere; 2021 May; 6(3):. PubMed ID: 33980684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All rabbits immunized with type A influenza virions have a serum haemagglutination-inhibition antibody response biased to a single epitope in antigenic site B.
    Lambkin R; Dimmock NJ
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():889-97. PubMed ID: 9049335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and specificity of the candidate multi-epitope-vaccines against HIV-1.
    Lu Y; Ding J; Chen YH
    Immunopharmacol Immunotoxicol; 2001 Nov; 23(4):487-94. PubMed ID: 11792008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
    Ramírez-Salinas GL; García-Machorro J; Rojas-Hernández S; Campos-Rodríguez R; de Oca AC; Gomez MM; Luciano R; Zimic M; Correa-Basurto J
    Arch Virol; 2020 Apr; 165(4):891-911. PubMed ID: 32060794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
    Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1.
    Li H; Liu ZQ; Ding J; Chen YH
    Immunol Lett; 2002 Nov; 84(2):153-7. PubMed ID: 12270553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
    Liu W; Zou P; Chen YH
    Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.
    Wong JA; Bhat R; Hockman D; Logan M; Chen C; Levin A; Frey SE; Belshe RB; Tyrrell DL; Law JL; Houghton M
    J Virol; 2014 Dec; 88(24):14278-88. PubMed ID: 25275133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of epitope recognition of antibodies induced by DNA immunization against hemagglutinin protein of influenza A virus.
    Tonegawa K; Nobusawa E; Nakajima K; Kato T; Kutsuna T; Kuroda K; Shibata T; Harada Y; Nakamura A; Itoh M
    Vaccine; 2003 Jul; 21(23):3118-25. PubMed ID: 12804838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.